Mission We are a diagnostic platform company developing a scalable single molecule detection platform enabling lower cost, rapid clinical liquid biopsy tests. Our vision is to enable inexpensive, fast, high complexity clinical diagnostic testing at scale. Our platform will transform the field of clinical molecular testing to a simpler, more actionable tool for physicians to benefit patient care. We accomplish this through honest, transparent, solution-oriented teamwork.
Description Founded in 2022, Enumera Molecular is dedicated to developing inexpensive, fast clinical diagnostic solutions to the liquid biopsy sector.